Business Standard

India capable of strengthening cold chain for Pfizer vaccine: Health secy

Rajesh Bhushan was responding to a query on the country's cold storage capacity for vaccines such as Pfizer's that need to be kept in minus 70 degree celsius

The Pfizer logo is seen at their world headquarters in New York
Premium

The Pfizer logo is seen at their world headquarters in New York

Ruchika ChitravanshiTE Narsimhan New Delhi
India is in a position to not only augment and strengthen but also add to its cold chain capabilities, Health Secretary Rajesh Bhushan said on Tuesday, in response to a query on the country’s cold storage capacity for vaccines such as Pfizer’s that need to be kept in minus 70 degrees Celsius.

The government has been in talks with US drugmaker Pfizer, which has reported that its vaccine BNT162b2 has been more than 90 per cent effective in late-stage trials. The vaccine developed with German biotech firm BioNTech will be reviewed by the US Food and Drug Administration this month. 

“We cannot

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in